The possible relevance of the expression of MHC antigens and of EGF receptor in aggressive oral tumours

International Journal of Oncology

Volumn 10, Issue 6, 1997, Pages 1217-1222

  Nouri, A M E ^a   Cannell, H ^a   Ong'uti, M ^a   Tezabwala, B U ^a   Oliver, R T D ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

MHC antigens; oral squamous cell carcinoma

Indexed keywords

CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOLESCENT; ADULT; AGED; AMELOBLASTOMA; ANTIGEN EXPRESSION; ARTICLE; BASAL CELL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031003218     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.6.1217     Document Type: Article

References (24)

1. Johnson NW, Warnakulasuriya S, Partridge M and Langdon JL: Oral cancer: a serious and growing problem. Ann Roy Coll Surg 77: 321-322, 1995.
2. Cancer in South East England. 192 pub. Thames Cancer Registry, pp 52-53, 1995.
3. Nouri AME, Smith MEF, Crosby D and Oliver RTD: Selective and non-selective loss of immunoregulatory molecules (HLA-A, B, C antigens and LFA-3) in transitional cell carcinoma. Br J Cancer 62: 603-606, 1990.
4. Smith MEF, March SGE, Bodmer JG, Gelsthorpe K and Bodmer WF: Loss of HLA-A, B, C allele products and lymphocyte function-associated antigens-3 in colorectal neoplasia. Proc Natl Acad Sci USA 86: 5557-5561, 1989.
5. Masucci KG, Torsteindottir S, Colombani J, Barut-Bar C, Klein E and Klein G: Down regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci USA 84: 4567-4571, 1987.
6. Fleming KA, McMichael A, Morton JA, Woods J and McGee JOD: Distribution of HLA class I antigens in normal human tissue and in mammary cancer. J Clin Pathol 34: 779-784, 1981.
7. Zinkernagal RM and Doherty PC: MHC cytotoxic T cell: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction specificity. Advan Immunol 27: 51-77, 1979.
8. Staton P, Ricachards S, Reeves J, Nikolic M, Edington K, Clark L, Robertson G, Souter D, Mitchell R, Hendler FJ, et al: Epidermal growth factor receptor by human squamous cell carcinoma of the head and neck cell lines and xenograft. Br J Cancer 70: 427-433, 1994.
9. Schreiber A, Schlessinger J'and Edidin M: Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells. J Cell Biol 98: 725-731, 1984.
10. Beger M, Greenfield C, Gullick W, et al: Evalution of epidermal growth factor receptors in bladder tumours. Br J Cancer 56: 533-537, 1987.
11. Yano H, Shiozaki K, Kobayashi K, Yano T, Tahara H and Tamura S: Immunohistologic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma. Cancer 67: 91-98, 1991.
12. Seward GR, Beales SJ, Johnson NW and Lumsden EGS: A metastasising ameloblastoma associated with renal calculi and hypercalcaemia. Cancer 36: 2277-2285, 1975.
13. Prescott S, James K, Hargreave TB, Chisholm DG and Smyth JF: Radio-immunoassy detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol 144: 1248-1253, 1990.
14. Prescott S, James K, Busuttil A, Hargreave TB, Chisholm DG and Smyth JF: HLA-DR expression by high grade superficial bladder cancer treated with BCG. Br J Cancer 63: 264-269, 1989.
15. Brodsky FM, Parham P, Bam CJ, Crumpton MJ and Bodmer WF: Monoclonal antibodies for analysis of the HLA system. J Immunol Rev 47: 342-349, 1979.
16. Lampson L and Levy R: Two populations of la molecules on a human B cell line. J Immunol 125: 293-299, 1980.
17. Nouri AME, Smith MEF, Crosby D and Oliver RTD: Selective loss of immunoregulatory molecules (HLA-A, B, C antigens and LFA-3) in transitional cell carcinoma. Br J Cancer 62: 603-606, 1990.
18. Hui K, Grosveld F and Festenstein H: Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated transformation. Nature 311: 750-752, 1984.
19. Nouri AME, Hussain RF, Dos Santos AVL, Gillott DJ and Oliver RTD: Induction of MHC antigens by tumour cell lines in response to interferons. Eur J Cancer 28: 1110-1115, 1992.
20. Nouri AME, Hussain RF and Oliver RTD: The frequency of MHC antigen abnormalities in urological tumours and their correction by gene transfection of cytokine stimulation. Cancer Gene Therapy 1: 119-123, 1994.
21. Ibrahim MA, Coode WK, Takei F, Ellis JS, Chain BM and Katz DR: Chemically modified antigen-presenting cells induce T lymphocyte allospecific hyporesponsiveness. J Immunol 147: 4086-4093, 1992.
22. Nouri AME, Hussain RF and Oliver RTD: Defective expression of adhesion molecules on bladder tumour and human tumour cell lines. Urol Int 56: 6-12, 1994.
23. Harris A, Smith K, Neal D, Fenneley J and Hall R: Epidermal growth factor expression correlates with tumour recurrence, stage progression and over all survival in human bladder cancer. Proc Am Assoc Cancer Res 29: 453-458, 1988.
24. Nouri AME, Hussain RF and Oliver RTD: Epidermal growth factor induced protection of tumour cell susceptibility to cytolysis. Eur J Cancer 31: 963-969, 1993.